There are no adequate and well-controlled studies in pregnancy and breast feeding women. The drug should not be administered to pregnant women during the first trimester of pregnancy and breast feeding women unless the potential benefits outweighs the potential risks associated with treatment.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
